Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

177Lu-PSMA-617 for the Treatment of Advanced Clear Cell Renal Cell Carcinoma, LASER Trial

Trial Status: active

This phase II trial studies how well 177Lu-PSMA-617 works in treating patients with clear cell renal cell carcinoma (ccRCC) that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Radioactive drugs, such as 177Lu-PSMA-617, may carry radiation directly to tumor cells to kill them and not harm normal cells.